SCHEMBL28113573

SCHEMBL28113573

Cc1cccc(-c2ccc(Cl)c(C(N)=O)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.56
AKR1C1 Q04828 1/20 0.56
DHODH Q02127 2/20 0.50
TLR8 Q9NR97 2/20 0.48
PARP1 P09874 1/20 0.47
IKBKB O14920 1/20 0.46
CDC7 O00311 1/20 0.46
MKNK1 Q9BUB5 2/20 0.46
MKNK2 Q9HBH9 2/20 0.46
ICMT O60725 2/20 0.45
CNR1 P21554 1/20 0.44
CSF1R P07333 1/20 0.44
FLT1 P17948 1/20 0.44
FLT3 P36888 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ERCC5 P28715 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL787118 0.85 AKR1C2 (0.70) AKR1C2AKR1C1DHODHLMNAERCC5
SCHEMBL787129 0.81 AKR1C2 (0.54) AKR1C2AKR1C1CNR1NPC1LMNA
SCHEMBL1786128 0.81 LMNA (0.50) PARP1NPC1LMNARAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL28752341 0.79 LMNA (0.49) PARP1NPC1LMNARAB9ASMN1; SMN2
SCHEMBL6667275 0.77 BCAT2 (0.65) DHODHTLR8PARP1CDC7NPC1
SCHEMBL12394209 0.76 DHODH (0.64) DHODHPARP1MKNK1MKNK2CSF1R
SCHEMBL6508314 0.75 AKR1C2 (0.70) AKR1C2AKR1C1DHODHCNR1SMN1; SMN2
SCHEMBL8365173 0.75 AHR (0.61) AKR1C2AKR1C1CNR1RAB9A
SCHEMBL29723862 0.75 PARP1 (0.52) AKR1C2AKR1C1DHODHTLR8PARP1
SCHEMBL5605353 0.74 PARP1 (0.78) DHODHTLR8PARP1ICMTCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106166157-A Sulfonamides heterocyclic carbamate derivatives as anti-hepatitis b virus infected antiviral agent 巴鲁·S·布隆伯格研究所 2016-11-30 CN claimed